ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 1012

The Global Prevalence of Rheumatoid Arthritis: A Meta-Analysis

Khalid Almutairi1, Johannes Nossent1, David Preen1, Helen Keen1 and Charles Inderjeeth1, 1The University of Western Australia, Perth, Western Australia, Australia

Meeting: ACR Convergence 2020

Keywords: Administrative Data, Epidemiology, meta-analysis, population studies, rheumatoid arthritis

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Epidemiology & Public Health Poster III: Inflammatory Rheumatic Disease

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

To determine the global population prevalence of rheumatoid arthritis (RA) based on published studies and assess factors that influence RA prevalence estimates.

Methods:

Four electronic databases were searched (ProQuest, MEDLINE, Web of Science, and EMBASE) for publications that reporting prevalence estimates of RA from 1980 and 2019. A random-effect meta-analysis model was used to produce the pooled prevalence estimates. The potential between-study heterogeneity was identified using sensitivity analysis, sub-group and meta-regression analyses.

Results:

A total of 67 studies were included in the meta-analysis, containing 742,246 RA patients and 211,592,925 healthy controls. The global RA prevalence estimate was 0.46% (95% confidence interval (CI): 0.39-0.54; I2=99.9%) with a 95% prediction interval (0.06–1.27). The RA point-prevalence was 0.45% (95% CI: 0.38- 0.53%) between 1986 and 2014, while the pooled period-prevalence was 0.46% (95% CI: 0.36% and 0.57%) from 1955 to 2015. The highest RA pooled prevalence (0.69%; 95% CI: 0.47–0.95) was derived from linked data sources studies. Based on meta-regression, the factors that explain the studies’ heterogeneity of RA prevalence, including geographical location, the risk bias assessment of studies and sample size.

Conclusion:

The global prevalence of RA between 1980 and 2019 was 460 per 100,000 population, with variations due to geographical location and study methodology. Linked data are the preferred method to estimate RA population prevalence as they provide the best case-ascertainment.

Figure 1: Forest plot of the pooled global prevalence of Rheumatoid Arthritis (RA) based on prevalence methods.

Table 1: The 95% prediction intervals for future RA prevalence estimates of different sub-groups category.


Disclosure: K. Almutairi, None; J. Nossent, None; D. Preen, None; H. Keen, Pfizer Australia, 8, Abbvie Australia, 8; C. Inderjeeth, Novartis Australia, 8, Amgen, 5, 8, Kiniksa, 2, Paradigm, 2, BMS, 2.

To cite this abstract in AMA style:

Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The Global Prevalence of Rheumatoid Arthritis: A Meta-Analysis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/the-global-prevalence-of-rheumatoid-arthritis-a-meta-analysis/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-global-prevalence-of-rheumatoid-arthritis-a-meta-analysis/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology